$OPCH
Option Care Health, Inc. Stock $opch

$opch Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000162828017004865 Filed on May 04, 2017

Income Statement

Concept	2017 Q2	2017 Q1	2016 Q1
Revenue	$218.1M	$217.8M	$238.5M
YoY Change	-6.18%	-8.66%	-2.41%
Cost Of Revenue	$150.5M	$152.9M	$174.2M
YoY Change	-10.58%	-12.22%	-2.88%
Gross Profit	$67.61M	$64.87M	$63.30M
YoY Change	6.87%	2.48%	-2.54%
Gross Profit Margin	31.0%	29.78%	26.55%
Selling, General & Admin	$15.80M	$16.30M	$18.60M
YoY Change	15.33%	-12.37%	-7.0%
% of Gross Profit	23.37%	25.13%	29.38%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$7.000M	$7.165M	$4.538M
YoY Change	62.79%	57.89%	-21.68%
% of Gross Profit	10.35%	11.04%	7.17%
Operating Expenses	$65.10M	$67.90M	$62.80M
YoY Change	11.09%	8.12%	-6.96%
Operating Profit	$2.511M	-$3.026M	-$1.273M
YoY Change	-46.19%	137.71%	-79.48%
Interest Expense	-$12.60M	-$12.70M	-$9.400M
YoY Change	32.63%	35.11%	2.17%
% of Operating Profit	-501.79%
Other Income/Expense, Net
YoY Change
Pretax Income	-$28.43M	-$18.80M	-$10.31M
YoY Change	224.2%	82.34%	-32.9%
Income Tax	$718.0K	$619.0K	$23.00K
% Of Pretax Income
Net Earnings	-$29.52M	-$19.72M	-$9.830M
YoY Change	237.41%	100.6%	-50.04%
Net Earnings / Revenue	-13.54%	-9.05%	-4.12%
Basic Earnings Per Share
Diluted Earnings Per Share	-$973.6K	-$663.3K	-$552.3K
COMMON SHARES
Basic Shares Outstanding	121.0M shares	121.0M shares	68.77M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q2	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$40.50M	$16.00M	$8.100M
YoY Change	-21.21%	97.53%	-65.09%
Cash & Equivalents	$40.53M	$15.97M	$8.049M
Short-Term Investments
Other Short-Term Assets	$18.10M	$20.00M	$19.90M
YoY Change	9.7%	0.5%	87.74%
Inventory	$28.82M	$30.55M	$29.12M
Prepaid Expenses
Receivables	$103.1M	$109.5M	$101.8M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$190.5M	$176.0M	$158.8M
YoY Change	-4.28%	10.81%	-25.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$30.06M	$30.42M	$30.48M
YoY Change	-2.36%	-0.22%	-15.16%
Goodwill	$365.9M	$365.9M	$308.7M
YoY Change	18.53%	18.53%	-46.15%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.204M	$2.173M	$1.130M
YoY Change	83.21%	92.3%	-9.38%
Total Long-Term Assets	$422.9M	$426.4M	$344.6M
YoY Change	22.85%	23.72%	-45.56%
TOTAL ASSETS
Total Short-Term Assets	$190.5M	$176.0M	$158.8M
Total Long-Term Assets	$422.9M	$426.4M	$344.6M
Total Assets	$613.4M	$602.4M	$503.5M
YoY Change	12.91%	19.65%	-40.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$46.38M	$47.45M	$53.08M
YoY Change	-5.13%	-10.62%	-41.74%
Accrued Expenses	$49.90M	$47.40M	$46.60M
YoY Change	25.06%	1.72%	6.64%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.700M	$22.40M	$32.20M
YoY Change	-81.91%	-30.43%	10633.33%
Total Short-Term Liabilities	$102.9M	$121.7M	$135.7M
YoY Change	1.2%	-10.29%	-6.52%
LONG-TERM LIABILITIES
Long-Term Debt	$475.7M	$450.1M	$391.7M
YoY Change	21.94%	14.91%	-6.4%
Other Long-Term Liabilities	$17.94M	$1.180M	$2.099M
YoY Change	984.11%	-43.78%	-20.97%
Total Long-Term Liabilities	$17.94M	$1.180M	$2.099M
YoY Change	984.11%	-43.78%	-20.97%
TOTAL LIABILITIES
Total Short-Term Liabilities	$102.9M	$121.7M	$135.7M
Total Long-Term Liabilities	$17.94M	$1.180M	$2.099M
Total Liabilities	$600.0M	$575.9M	$529.9M
YoY Change	21.46%	8.67%	-9.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$692.0M	-$662.8M	-$611.4M
YoY Change	11.68%	8.41%	89.96%
Common Stock	$628.6M	$615.0M	$530.7M
YoY Change	2.6%	15.89%	-1.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$10.75M
YoY Change			0.36%
Treasury Stock Shares			2.661M shares
Shareholders Equity	-$63.49M	-$47.86M	-$91.52M
YoY Change
Total Liabilities & Shareholders Equity	$613.4M	$602.4M	$503.5M
YoY Change	12.91%	19.65%	-40.44%

Cashflow Statement

Concept	2017 Q2	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	-$29.52M	-$19.72M	-$9.830M
YoY Change	237.41%	100.6%	-50.04%
Depreciation, Depletion And Amortization	$7.000M	$7.165M	$4.538M
YoY Change	62.79%	57.89%	-21.68%
Cash From Operating Activities	$6.000M	-$11.03M	-$10.96M
YoY Change	-156.6%	0.64%	-60.91%
INVESTING ACTIVITIES
Capital Expenditures	-$2.600M	$1.684M	$2.429M
YoY Change	-16.13%	-30.67%	-215.67%
Acquisitions
YoY Change
Other Investing Activities			$1.100M
YoY Change
Cash From Investing Activities	-$2.600M	-$1.684M	-$1.324M
YoY Change	-13.33%	27.19%	-35.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$5.052M	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	21.10M	$24.25M	$4.759M
YoY Change	-62.98%	409.54%	-90.96%
NET CHANGE
Cash From Operating Activities	6.000M	-$11.03M	-$10.96M
Cash From Investing Activities	-2.600M	-$1.684M	-$1.324M
Cash From Financing Activities	21.10M	$24.25M	$4.759M
Net Change In Cash	24.50M	$11.53M	-$7.528M
YoY Change	-43.55%	-253.19%	-133.45%
FREE CASH FLOW
Cash From Operating Activities	$6.000M	-$11.03M	-$10.96M
Capital Expenditures	-$2.600M	$1.684M	$2.429M
Free Cash Flow	$8.600M	-$12.72M	-$13.39M
YoY Change	-214.67%	-5.04%	-48.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q1	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	-51000	USD
CY2017Q1	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	0	USD
CY2016Q1	bios	Gain Losson Dispositionof Property Plant Equipment1 GainLossonDispositionofPropertyPlantEquipment1	939000	USD
CY2017Q1	bios	Gain Losson Dispositionof Property Plant Equipment1 GainLossonDispositionofPropertyPlantEquipment1	0	USD
CY2016Q1	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	321000	USD
CY2017Q1	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	645000	USD
CY2016Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	42191000	USD
CY2017Q1	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	41867000	USD
CY2016Q1	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	2667000	USD
CY2017Q1	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	3223000	USD
CY2016Q4	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	3799000	USD
CY2017Q1	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	4444000	USD
CY2016Q1	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	-51000	USD
CY2017Q1	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	0	USD
CY2015Q3	bios	Proceedsfrom Issuanceof Equityand Temporary Equity ProceedsfromIssuanceofEquityandTemporaryEquity	1100000	USD
CY2016Q2	bios	Saleof Stock Equity Issuable Amount SaleofStockEquityIssuableAmount	200000000	USD
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001014739
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	120982543	shares
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	BioScrip, Inc.
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	59134000	USD
CY2017Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	47446000	USD
CY2016Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	156541000	USD
CY2017Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	153538000	USD
CY2016Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	111811000	USD
CY2017Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	109477000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	611844000	USD
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	614977000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	44730000	USD
CY2017Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	44061000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	44730000	USD
CY2017Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	44061000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1003000	USD
CY2017Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1318000	USD
CY2016Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4538000	USD
CY2017Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6988000	USD
CY2016Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17500000	shares
CY2017Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	19400000	shares
CY2016Q4	us-gaap	Assets Assets	607740000	USD
CY2017Q1	us-gaap	Assets Assets	602417000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	176052000	USD
CY2017Q1	us-gaap	Assets Current AssetsCurrent	176023000	USD
CY2016Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	362000	USD
CY2017Q1	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	17000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15577000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8049000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9569000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15969000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-7528000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	6400000	USD
CY2016Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-5989000	USD
CY2017Q1	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-437000	USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	117682543	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	120982543	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	117682543	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	120982543	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2016Q1	us-gaap	Cost Of Revenue CostOfRevenue	174230000	USD
CY2017Q1	us-gaap	Cost Of Revenue CostOfRevenue	152226000	USD
CY2016Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2017Q1	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2016Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2017Q1	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2016Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2017Q1	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2016Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	17000	USD
CY2017Q1	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	495000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	12452000	USD
CY2017Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	12271000	USD
CY2016Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	23000	USD
CY2017Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	619000	USD
CY2016Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	6000	USD
CY2017Q1	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	124000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	2281000	USD
CY2017Q1	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	2900000	USD
CY2016Q1	us-gaap	Depreciation Depreciation	4538000	USD
CY2017Q1	us-gaap	Depreciation Depreciation	6988000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.17
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.18
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31043000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27858000	USD
CY2016Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	939000	USD
CY2017Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11051000	USD
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9479000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	365947000	USD
CY2017Q1	us-gaap	Goodwill Goodwill	365947000	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	64232000	USD
CY2017Q1	us-gaap	Gross Profit GrossProfit	65584000	USD
CY2016Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	238462000	USD
CY2017Q1	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	217810000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-9770000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-18991000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-9747000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18372000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.17
CY2017Q1	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.18
CY2016Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	233000	USD
CY2017Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-437000	USD
CY2016Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
CY2017Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	23000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	619000	USD
CY2016Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	3388000	USD
CY2017Q1	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6976000	USD
CY2016Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3411000	USD
CY2017Q1	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-6445000	USD
CY2016Q1	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	62000	USD
CY2017Q1	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	52000	USD
CY2016Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-16000	USD
CY2017Q1	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	36000	USD
CY2016Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	13000	USD
CY2017Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	125000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-11995000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-11688000	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-174000	USD
CY2017Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-619000	USD
CY2016Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-4630000	USD
CY2017Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-1157000	USD
CY2016Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-13867000	USD
CY2017Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-5616000	USD
CY2016Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-2548000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-401000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-7897000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3601000	USD
CY2016Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	4417000	USD
CY2017Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-2333000	USD
CY2016Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2017Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	5132000	USD
CY2016Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9412000	USD
CY2017Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-12744000	USD
CY2016Q1	us-gaap	Interest Paid Net InterestPaidNet	13143000	USD
CY2017Q1	us-gaap	Interest Paid Net InterestPaidNet	12548000	USD
CY2016Q4	us-gaap	Interest Payable Current InterestPayableCurrent	6705000	USD
CY2017Q1	us-gaap	Interest Payable Current InterestPayableCurrent	5549000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	36165000	USD
CY2017Q1	us-gaap	Inventory Net InventoryNet	30549000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	567301000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	575884000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	607740000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	602417000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	130350000	USD
CY2017Q1	us-gaap	Liabilities Current LiabilitiesCurrent	121732000	USD
CY2017Q1	us-gaap	Long Term Debt LongTermDebt	402937000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	433413000	USD
CY2017Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	450072000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	18521000	USD
CY2017Q1	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	22426000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	451934000	USD
CY2017Q1	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	472498000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4759000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24249000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1324000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6816000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10963000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11033000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4974000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-10596000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-9537000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-19428000	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11707000	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-21816000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2163000	USD
CY2017Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2173000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1257000	USD
CY2017Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1180000	USD
CY2016Q1	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	39658000	USD
CY2017Q1	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	44358000	USD
CY2016Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2429000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1684000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18507000	USD
CY2017Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14896000	USD
CY2016Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	0	USD
CY2017Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	23060000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5052000	USD
CY2016Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	21000000	USD
CY2017Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	563000	USD
CY2016Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-53000	USD
CY2017Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-51000	USD
CY2016Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-3137000	USD
CY2017Q1	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-3137000	USD
CY2016Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1105000	USD
CY2017Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32535000	USD
CY2017Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30416000	USD
CY2016Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7592000	USD
CY2017Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7164000	USD
CY2016Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	111811000	USD
CY2017Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	109477000	USD
CY2016Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	51000	USD
CY2017Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	238000	USD
CY2016Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	13000000	USD
CY2017Q1	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	1000000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	5132000	USD
CY2016Q1	us-gaap	Restructuring Charges RestructuringCharges	2254000	USD
CY2017Q1	us-gaap	Restructuring Charges RestructuringCharges	3206000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-643419000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-662847000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1474000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	521000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-31563000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	-47858000	USD
CY2016Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	172000	USD
CY2017Q1	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	174000	USD
CY2016Q1	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	1998000	USD
CY2017Q1	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	2214000	USD
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	68771000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	118783000	shares

Files In Submission

Name	View Source	Status
0001628280-17-004865-index-headers.html	Edgar Link	pending
0001628280-17-004865-index.html	Edgar Link	pending
0001628280-17-004865.txt	Edgar Link	pending
0001628280-17-004865-xbrl.zip	Edgar Link	pending
bios-20170331.xml	Edgar Link	completed
bios-20170331.xsd	Edgar Link	pending
bios-20170331x10q.htm	Edgar Link	pending
bios-20170331_cal.xml	Edgar Link	unprocessable
bios-20170331_def.xml	Edgar Link	unprocessable
bios-20170331_lab.xml	Edgar Link	unprocessable
bios-20170331_pre.xml	Edgar Link	unprocessable
bios-ex311x20170331x10q.htm	Edgar Link	pending
bios-ex312x20170331x10q.htm	Edgar Link	pending
bios-ex321x20170331x10q.htm	Edgar Link	pending
bios-ex322x20170331x10q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
logowithregisteredtm05.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPCH
Option Care Health, Inc. Stock $opch

2017 Q2 Form 10-Q Financial Statement

#000162828017004865 Filed on May 04, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH Option Care Health, Inc. Stock $opch

2017 Q2 Form 10-Q Financial Statement

#000162828017004865 Filed on May 04, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH
Option Care Health, Inc. Stock $opch